Syracuse

Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d’Ivoire, Mali and Senegal

Archive ouverte

Rouveau, Nicolas | Ky-Zerbo, Odette | Boye, Sokhna | Fotso, Arlette, Simo | d’Elbée, Marc | Maheu-Giroux, Mathieu | Silhol, Romain | Kouassi, Arsène, Kra | Vautier, Anthony | Doumenc-Aïdara, Clémence | Breton, Guillaume | Keita, Abdelaye | Ehui, Eboi | Ndour, Cheikh, Tidiane | Boilly, Marie-Claude | Terris-Prestholt, Fern | Pourette, Dolorès | Desclaux, Alice | Larmarange, Joseph

Edité par CCSD ; BioMed Central -

International audience. Background: The ATLAS programme aims to promote and implement HIV self-testing (HIVST) in three West African countries: Côte d'Ivoire, Mali, and Senegal. During 2019-2021, in close collaboration with the national AIDS implementing partners and communities, ATLAS plans to distribute 500,000 HIVST kits through eight delivery channels, combining facility-based, community-based strategies, primary and secondary distribution of HIVST. Considering the characteristics of West African HIV epidemics, the targets of the ATLAS programme are hard-to-reach populations: key populations (female sex workers, men who have sex with men, and drug users), their clients or sexual partners, partners of people living with HIV and patients diagnosed with sexually transmitted infections and their partners. The ATLAS programme includes research support implementation to generate evidence for HIVST scale-up in West Africa. The main objective is to describe, analyse and understand the social, health, epidemiological effects and costeffectiveness of HIVST introduction in Côte d'Ivoire, Mali and Senegal to improve the overall HIV testing strategy (accessibility, efficacy, ethics).

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion